News ArticleGlobal Health Limited Posts Rs. 1812.59 Million Q2 Profit After Tax and Sanctions Rs. 997 Crore Ghaziabad Hospital Project
Company approves construction budget for 500-bed hospital on UPAVP land and reports unmodified limited review for Q2 and H1 FY2026-27 results
Global Health Limited declared its unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026. The Company reported a profit after tax of Rs. 1,812.59 million for Q2 and approved a Rs. 997 crore budget for constructing a 500-bed hospital in Ghaziabad, Uttar Pradesh. The results were reviewed with an unmodified opinion by statutory auditors Walker Chandiok & Co LLP.
Global Health Limited
Financial Results
Global Health Limited announced unaudited financial results for the quarter and half year ended September 30, 2026, posting a profit after tax of Rs. 1,812.59 million for Q2. Concurrently, the board approved a Rs. 997 crore budget for constructing a new 500-bed hospital in Ghaziabad, Uttar Pradesh, on land allocated by the UP Housing & Development Board.
The company’s standalone revenue from operations for Q2 was Rs. 12,080.94 million, with total income including other income reaching Rs. 12,339.83 million. Total expenses for the quarter amounted to Rs. 9,909.07 million, resulting in a profit before tax of Rs. 2,000.76 million.
The approved hospital project covers a land area of 10,560.36 square meters located at Siddharth Vihar Yojna, Ghaziabad, Uttar Pradesh. This project budget includes land costs, emphasizing GHL's expansion into new healthcare infrastructure.
The limited review conducted by statutory auditors Walker Chandiok & Co LLP resulted in an unqualified opinion on the financial statements, confirming compliance with accounting standards and SEBI regulations.
The trading window related to the result declaration will reopen 48 hours after these disclosures, following regulatory guidelines.
Highlights
- Profit after tax for Q2 stands at Rs. 1,812.59 million.
- Revenue from operations in Q2 reported at Rs. 12,080.94 million.
- Board approves Rs. 997 crore budget for 500-bed hospital construction in Ghaziabad on 10,560.36 sq. meters land.
- Limited Review Report issued with unqualified opinion by Walker Chandiok & Co LLP.
- Trading window to open after 48 hours post results disclosure.
- Results cover second quarter and half year ended September 30, 2026.
Key Data Snapshot
What happened
- Global Health Limited approved its unaudited standalone and consolidated financial results for Q2 and half year ended September 30, 2026.
- The company reported a profit after tax (PAT) of Rs. 1,812.59 million for the quarter.
- The Board approved a Rs. 997 crore budget for building a 500-bed hospital in Ghaziabad, Uttar Pradesh.
- The land for the project is allotted by the UP Housing & Development Board and measures 10,560.36 sq. meters.
Financial performance
- Total income for Q2 was Rs. 12,339.83 million including other income of Rs. 258.89 million.
- Total expenses for the quarter were Rs. 9,909.07 million.
- Profit before tax stood at Rs. 2,000.76 million for Q2.
- The limited review by Walker Chandiok & Co LLP issued an unqualified (unmodified) opinion on the financials.
Order and execution details
- The Rs. 997 crore project budget covers construction and cost of land.
- The hospital to have 500 beds and will be situated on the designated land in Siddharth Vihar Yojna, Ghaziabad.
- This project is part of the company's ongoing capacity expansion plans.
Regulatory and governance context
- Results were declared following applicable SEBI Listing Regulations.
- Trading window to open 48 hours after the results disclosure.
- Statement accompanied by Limited Review Report as required under SEBI regulations.
Highlights
- Profit after tax for Q2 stands at Rs. 1,812.59 million.
- Revenue from operations in Q2 reported at Rs. 12,080.94 million.
- Board approves Rs. 997 crore budget for 500-bed hospital construction in Ghaziabad on 10,560.36 sq. meters land.
- Limited Review Report issued with unqualified opinion by Walker Chandiok & Co LLP.
- Trading window to open after 48 hours post results disclosure.
- Results cover second quarter and half year ended September 30, 2026.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Indian Accounting Standard 34 (Ind AS 34)
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Biocon Limited Reports Rs. 1,439 Million Profit for H1 FY2026-27; Appoints Mukesh Rathi as New CTO from January 2027
Biocon Limited declared its unaudited standalone financial results for the quarter and half-year ended September 30, 2026, reporting a profit of Rs. 1,439 million for the half-year. Alongside financial disclosure, the company announced a change in its senior management with the resignation of CTO Dr. Mandar Shrikant Ghatnekar effective December 31, 2026, and the appointment of Mr. Mukesh Rathi as the new CTO starting January 1, 2027.
Read Full Story
Zydus Lifesciences Posts ₹10,541 Million Net Profit for Half Year Ending September 30, 2026
Zydus Lifesciences Limited announced its unaudited standalone financial results for the quarter and half year ended September 30, 2026, recording a net profit of ₹7,145 million for Q2 and ₹10,541 million for the half year.
Read Full Story
Fractal Analytics Limited Reports Unaudited Q2 and H1 2026 Financial Results and Approves Winding Up of Analytics Vidhya Inc
Fractal Analytics Limited announced its unaudited consolidated and standalone financial results for the quarter and half-year ended September 30, 2026. Additionally, the company's Board has approved winding up its step-down subsidiary Analytics Vidhya Inc., aiming to simplify group corporate structure and enhance operational efficiency without affecting ongoing business activities.
Read Full Story
